Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the...
read more
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into an exclusive
partnership with Inception Sciences, Inc., and Versant Ventures to create Inception 5, a new company
dedicated to the research and development of novel small ...
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
Marken announced today the appointment of Paul J. Rice as Vice President, Logistics, EMEA Region. Mr. Rice will be based in London but will have responsibility for the branches and associated business in Europe and Africa including: Paris, London, ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc (“CML”), a global leader in pharmaceutical API development ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet...
read more
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau...
read more
Recipharm Karlskoga AB, specialized in the manufacture of semi-solid products, and Pharmanest
AB, a Stockholm-based pharmaceutical company specializing in developing products for local pain
relief in obstetrics and gynecology, are pleased to ...
read more
PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Company”), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services (“ATLAS”), a ...
read more
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and...
read more
Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for four of Alkermes’ pipeline candidates for the treatment of central nervous system (CNS) disorders: aripiprazole...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), is pleased to announce the 20th anniversary of its site located at Zwickau in Germany. The facility possesses multiple solid oral dosage form technologies and service ...
read more
Particle Sciences, Inc. has expanded its development
capabilities to accommodate the increasing demand for biopharmaceutical formulation and
analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business
Development ...
read more
Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, and Fluofarma, a contract research organization specializing in high content analysis, have ...
read more
Theorem Clinical Research and Excel Life Sciences
(ELS) have formed a strategic relationship to bolster Theorem’s clinical development offerings in
India, including local site management expertise. ELS has long-standing relationships with more
...
read more